In the news today: A new multi million pound laboratory in west London is to be the first institute in Europe to sequence patients genomes in a matter of days for personalised cancer treatment. The Tumour Profiling Unit run by The Institute of Cancer Research (ICR) in Chelsea will use state-of-the-art techniques such as genome sequencing, epigenetics and imaging to identify a patient’s cancer at the start of diagnosis then track the cancer as it progresses, mutates and develops resistance to drugs throughout a patient’s course of treatment, writes our science reporter Asha Tanna . In the next five to ten years tumour molecular profiling for cancer therapies should be "absolute routine practice" for every patient. The comment from ICR’s chief executive Alan Ashworth, professor of molecular biology went on: “Every cancer is different to every patient. But they are built from the same principles that they have to do certain things to clarify them as a cancer. “...
Hi my name is Nina-Ann I am a twice cancer survivor. Surviving cancer twice is a tough gig. I am sharing my journey to help others. I have written a book also. I am covering cancer, double mastectomy, chemotherapy, family and friends. My blog has lots of information, helpful and a few things to brighten your day. I am a cancer advocate. My story is happy, sad and inspirational. https://www.google.com.au/search?q=i+am+still+a+woman&ie=UTF-8&oe=UTF-8&hl=en-au&client=safari